CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 29, 2013	Sep. 30, 2012
Statement of Cash Flows [Abstract]
Net cash provided by operating activities	$ 825,103	$ 712,498
Cash flows from investing activities:
Capital expenditures	(111,690)	(95,329)
Origination of finance receivables	(2,617,100)	(2,328,653)
Collections on finance receivables	2,170,919	2,131,025
Purchases of marketable securities	(4,998)	(4,993)
Sales and redemptions of marketable securities	17,105	23,046
Other	6,721	0
Net cash used by investing activities	(539,043)	(274,904)
Cash flows from financing activities:
Proceeds from issuance of medium-term notes	0	993,737
Repayments of medium-term notes	(27,858)	0
Proceeds from securitization debt	647,516	763,895
Repayments of securitization debt	(650,424)	(1,161,592)
Net increase (decrease) in credit facilities and unsecured commercial paper	99,416	(634,874)
Borrowings of asset-backed commercial paper	69,555	182,131
Repayments of asset-backed commercial paper	(58,990)	(6,538)
Net change in restricted cash	(6,321)	12,255
Dividends paid	(140,772)	(106,560)
Purchase of common stock for treasury	(302,196)	(257,981)
Excess tax benefits from share-based payments	18,444	16,390
Issuance of common stock under employee stock option plans	39,145	36,342
Net cash used by financing activities	(312,485)	(162,795)
Effect of exchange rate changes on cash and cash equivalents	(11,758)	(6,608)
Net increase (decrease) in cash and cash equivalents	(38,183)	268,191
Cash and cash equivalents:
Cash and cash equivalents—beginning of period	1,068,138	1,526,950
Net increase (decrease) in cash and cash equivalents	(38,183)	268,191
Cash and cash equivalents—end of period	$ 1,029,955	$ 1,795,141